Baum M, Zamir O, Bergman-Rios R, Katz E, Beider Z, Cohen A, Banai M
Department of Bacteriology, Kimron Veterinary Institute, Beit Dagar, Israel.
J Clin Microbiol. 1995 Aug;33(8):2166-70. doi: 10.1128/jcm.33.8.2166-2170.1995.
The diagnosis of brucellosis in cattle and small ruminants requires the use of more than one serological test. The complement fixation test (CFT), the rose bengal test (RBT), and the serum agglutination test (SAT) are among the most useful tests for routine diagnosis. The microagglutination test (MAT) was developed as a simpler and more efficient test than the SAT. The relative efficacy of this test compared with that of the SAT was evaluated by using brucella-free sheep and goats prior to and after vaccination treatment. The specificities of the MAT and the SAT were 100%. Of the ewes and goats with a vaccination history, one ewe, expectedly a negative responder, had reactions in the MAT, the complement fixation test, and the rose bengal test but not in the SAT, suggesting a lower sensitivity of the SAT in this case. The calculated sensitivities of the MAT and the SAT were 93.9%. The agreement between MAT and SAT results from nonresponders was examined by using sera from unvaccinated lambs and kids (95.2% agreement), unvaccinated ewes and goats (84.4%), and ewes and goats with a vaccination history (43.9%). For the latter group higher levels of agglutination units were observed by the MAT than by the SAT in 51.5% of the samples. In testing sera from positive reactors after vaccination neither method was superior (MAT values were greater than SAT values for 23.5% of the samples, and MAT values were less than SAT values for 21.9% of the samples). Comparison of the methods on the individual sample level revealed a significant correlation between the MAT and the SAT (r = 0.96 +/- 0.005; P < 0.001). Since the MAT is simpler to perform than the SAT and can potentially be automated, the inclusion of the MAT as a supplementary test in brucellosis control programs is recommended.
牛和小反刍动物布鲁氏菌病的诊断需要使用不止一种血清学检测方法。补体结合试验(CFT)、孟加拉红试验(RBT)和血清凝集试验(SAT)是常规诊断中最有用的检测方法。微凝集试验(MAT)是作为一种比SAT更简单、更有效的检测方法而开发的。在接种疫苗治疗前后,使用无布鲁氏菌的绵羊和山羊评估了该检测方法与SAT相比的相对效力。MAT和SAT的特异性均为100%。在有疫苗接种史的母羊和山羊中,有一只母羊,不出所料是阴性反应者,在MAT、补体结合试验和孟加拉红试验中出现反应,但在SAT中未出现反应,这表明在这种情况下SAT的敏感性较低。计算得出的MAT和SAT的敏感性为93.9%。使用未接种疫苗的羔羊和幼畜的血清(一致性为95.2%)、未接种疫苗的母羊和山羊的血清(一致性为84.4%)以及有疫苗接种史的母羊和山羊的血清(一致性为43.9%),对无反应者的MAT和SAT结果之间的一致性进行了检测。对于后一组,在51.5%的样本中,MAT观察到的凝集单位水平高于SAT。在检测接种疫苗后阳性反应动物的血清时,两种方法都不具有优势(23.5%的样本MAT值大于SAT值,21.9%的样本MAT值小于SAT值)。在个体样本水平上对这些方法进行比较,发现MAT和SAT之间存在显著相关性(r = 0.96±0.005;P < 0.001)。由于MAT比SAT操作更简单,并且有可能实现自动化,因此建议在布鲁氏菌病控制计划中纳入MAT作为补充检测方法。